CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Syner-Med Improves Sales Execution with Veeva OpenData

Veeva Systems has announced that Syner-Med (PP) Ltd., a fast-growing U.K. pharmaceutical company, is using Veeva OpenData and Veeva CRM to empower field teams with accurate customer data and drive smarter engagement with customers. Veeva OpenData and Veeva CRM are part of Veeva Commercial Cloud, a suite of applications that Syner-Med is adopting to establish a foundation for their commercial operations as the company launches more new products over the next two years.
“Veeva delivers quality customer data, right in CRM, to improve our sales execution and create more valued interactions with our customers,” said Dipak Bhatti, managing director of Syner-Med. “We now have the foundation in place for a consistent commercial approach and to support our future growth.”
Syner-Med’s previous data sources limited their ability to track customer activities and placed a heavy administrative burden on field reps to maintain accurate customer data. Data change requests could often take weeks, so sales and marketing teams worked from outdated information and had a fragmented view of customer engagement across the company.
Veeva brings together complete customer data and multichannel engagement to help Syner-Med achieve greater commercial effectiveness. Veeva OpenData keeps data current using a combination of data science and Veeva data stewards that can make change requests within two hours versus the industry average of 10 days or more. As a result, field teams have an accurate view of their customers in Veeva CRM to deliver smarter, more informed interactions.
“Quality customer data is key to successful commercial execution and increased sales and marketing efficiency,” said Rebecca Silver, global vice president of Veeva OpenData. “With accurate data in Veeva CRM, Syner-Med field and medical teams can drive more value-based conversations with their customers.”
Veeva OpenData delivers access to approximately 16 million healthcare professionals (HCPs) and their healthcare organizations (HCOs) spanning 42 countries. Veeva OpenData can help customers achieve greater commercial success and improve sales execution and customer engagement.
Looking ahead, Syner-Med plans to adopt additional Veeva Commercial Cloud applications, including Veeva Vault PromoMats to combine creation, review, and distribution of commercial content with digital asset management; Veeva Align to perform fast, accurate territory alignments; Veeva CRM Approved Email and Veeva CRM Engage to extend reach through digital channels such as email, online meetings, and virtual events; and Veeva CLM to tailor calls and make sales materials easy to access and share.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026